Summary
Neurorx inc
Founded in 2015
Description
NRx creates innovative, life-saving treatments to address unmet medical needs and bring hope to those with chronic conditions. Learn More.
Strengths
- Neurorx inc has a strong market share in their industry
- Revenue generated per employee is greater than industry average
- Demonstrating revenue growth that is faster than the industry average
- The number of employees is growing faster than the industry average
- Since Neurorx inc was founded, the company has grown faster than the industry average
- Web traffic rankings are better than the industry average
Weaknesses
- Variance of revenue growth is more than the industry average
Annual Revenue
Neurorx inc's annual revenue
$423000
Based on Kona Equity data
-
Revenue per employee
$211500
-
Variance of revenue growth
4.28
-
Annual revenue growth since founding
$47000
-
Revenue growth rate from first known quarter to current
517.5%
Employee Count
2 employees
-
Employee growth rate from first known quarter to current
511.8%
Executives
Robert Risinger
Vice President, Clinical Development
r**@neurorxpharma.comSeth Vanvoorhees
Chief Financial Officer &Treasurer
s**@neurorxpharma.comStephen Willard
CEO
s**@neurorxpharma.comRouba Khayata
Clinical Trial Assistant
r**@neurorxpharma.comSean Nealon
Partner
s**@neurorxpharma.comSeth Vanvorhees
Chief Financial Officer
s**@neurorxpharma.comRobert Besthof
Head of Operations & Chief Commercial Officer
r**@neurorxpharma.comMichael Brown
Executive Director
m**@neurorxpharma.comDawn Langford
Operations
d**@neurorxpharma.comYajing Shen
Mri Reader
y**@neurorxpharma.comDennis Mcbride
Chief Strategy Officer & Senior Scientist
d**@neurorxpharma.comThomas Brockwell
Managing Director
t**@neurorxpharma.comRobert Gold
Development Partner
r**@neurorxpharma.comAndrea Robichaud
Team Leader, Project Management
a**@neurorxpharma.comAlexandre Gervais
Cta
a**@neurorxpharma.comPhilip Lavin
Chief Methodologist
p**@neurorxpharma.comEllis Wilson
Vice President, Clinical Development
e**@neurorxpharma.comDavid Fritchie
President
d**@neurorxpharma.comMolly Cogan
Senior Director, Global Communications
m**@neurorxpharma.comCatherine Mardakis
Project Manager
c**@neurorxpharma.comBrian Buono
Chief Legal Officer
b**@neurorxpharma.comRandolph Guggenheimer
Chief Business Officer
r**@neurorxpharma.comBennett Kim
Chief Investment Officer
b**@neurorxpharma.comPhone Pharmaceuticals
Chief Executive Officer
p**@neurorxpharma.comHeather Lothamer
Associate Director, Clinical Operations & Medical
h**@neurorxpharma.comMichael Kunz
Deputy General Counsel
m**@neurorxpharma.comPamela Edison
Product Development and Clinical Trials
p**@neurorxpharma.comKim Bennett
Chief Investment Officer
k**@neurorxpharma.comG Score - 6
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G2 Income per employee more than industry average.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G4 Employee growth rate from the first known quarter to current is higher than the industry average.
- G6 Annual revenue growth since founding is higher than the industry average.
- G7 Website traffic rankings are better than the industry average
Web Analysis
-
Rank
708 K
-
Page views per visitor
4.0
-
Daily time
2:16
-
Bounce Rate
42.9 %
Location
Unlock unlimited leads
Similar Companies
Prelude Therapeutics Inc.
preludetx.com- Founded in 2016
- Location: Wilmington, DE
- Annual Revenue: $39.2M
- Employees: 118
- Prelude Therapeutics is a clinical stage precision oncology company developing innovative drug candidates targeting critical cancer cell pathways. Preludes diverse pipeline is comprised of highly differentiated, potentially best in class and first in ...
Ayala Pharmaceuticals Inc
ayalapharma.com- Founded in 2017
- Location: Wilmington, DE
- Annual Revenue: $250.0K
- Employees: 15
- We aim to transform lives Compassion, integrity and efficiency are at the center of everything we do to impact the lives of people living with rare cancers. Our Approach SCROLL OUR PROMISE Science Driven by People We focus on the cure At Ayala, we are ...
Marlex Pharmaceuticals Inc
marlexpharm.com- Founded in 1992
- Location: New Castle, DE
- Annual Revenue: $12.6M
- Employees: 27
- Marlex Pharmaceuticals is a leading pharmaceutical distribution company that focuses on supply chain efficiencies, operational excellence, and patient safety. With a wide range of products consisting of generic, consumer, and specialty pharmaceuticals,...
Automedica LLC
automedica.com- Location: Wilmington, DE
- Annual Revenue: $5.3M
- Employees: 26
Advanced Materials Technology Inc
advanced-materials-tech.com- Location: Wilmington, DE
- Annual Revenue: $6.7M
- Employees: 25
- HALO is a leader in high performance liquid chromatography columns. Improve efficiency and analyze faster with our HPLC columns. Learn more.
Techfields Pharma Co. Ltd
tfpharma.com- Founded in 2016
- Location: Dover, DE
- Annual Revenue: $5.7M
- Employees: 13
- Techfields Inc. is a pharmaceutical company that focuses on revolutionizing the way therapeutics enter the body. They aim to make drugs faster acting, safer, and more effective. Techfields takes approved therapeutics and transforms them for better upta...
Key Information
- Name: Neurorx inc
- Category: Pharmaceuticals
- SIC: 2834; 283
- NAICS: 32541; 325
See similar companies
-
By City Wilmington Pharmaceuticals in Wilmington Small Pharmaceuticals in Wilmington Mid-size Pharmaceuticals in Wilmington
-
By State DE Small companies in DE Pharmaceuticals in DE Small Pharmaceuticals in DE Mid-size Pharmaceuticals in DE
-
By Category Pharmaceuticals Small Pharmaceuticals Mid-size Pharmaceuticals G Score of 6
-
Firmographic data G Score of 6 Founded in 2015 SIC: 2834 SIC: 283 NAICS: 32541 NAICS: 325 #Pharmaceuticals #Healthcare #Drug Manufacturing & Research #Biotechnology
Frequently Asked Questions
Neurorx inc's headquarters are located at 913 North Market Street, Suite 200 Wilmington, DE 19801.
Neurorx inc's official website is neurorxpharma.com
Neurorx inc's annual revenue is $423.0 K.
Neurorx inc's SIC: 2834; 283
Neurorx inc's NAICS: 32541; 325.
Neurorx inc has 2 employees
Neurorx inc is in the industry of Pharmaceuticals.
